Taking into account the International Conference Harmonisation E5 framework for bridging studies, this book covers the regulatory requirements, scientific and practical issues, and statistical methodology for designing and evaluating bridging studies and multiregional clinical trials. For bridging studies, the authors explore ethnic sensitivity,
Inhaltsverzeichnis
Bridging Diversity: Extrapolating Foreign Data to a New Region. Two-Stage Designs of Bridging Studies. Consistency of Treatment Effects in Bridging Studies and Global Multiregional Trials. Assessing Similarity Using the Reproducibility and Generalizability Probabilities and the Sensitivity Index. Combining Information in Clinical Drug Development: Bridging Studies and Beyond. A Bayesian Approach for Evaluation of Bridging Studies. Issues of Sample Size in Bridging Trials and Global Clinical Trials. Design and Sample Size Considerations for Global Trials. Application of Genomic Technologies for Bridging Strategy Involving Different Race and Ethnicity in Pharmacogenomics Clinical Trials. Interaction Effects in Bridging Studies. Multiregional Clinical Trials. Multiregional Clinical Trials for Global Simultaneous Drug Development in Japan. Feasibility and Implementation of Bridging Studies in Taiwan. Index.